Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02LCI
|
|||
| Former ID |
DIB014643
|
|||
| Drug Name |
TA-5493
|
|||
| Synonyms |
P38 inhibitor (rheumatoid arthritis/ psoriasis), Mitsubishi Tanabe
Click to Show/Hide
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Discontinued in Phase 1 | [1] | |
| Company |
Tanabe Seiyaku Co Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Stress-activated protein kinase (p38) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022792) | |||
| REF 2 | US patent application no. 2008,0269,123, Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.